AdaptHealth Corp. logo AHCO - AdaptHealth Corp.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 9
HOLD 2
SELL 1
STRONG
SELL 0
| PRICE TARGET: $10.00 DETAILS
HIGH: $13.00
LOW: $8.00
MEDIAN: $10.00
CONSENSUS: $10.00
UPSIDE: 78.89%

Stock News

ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health

ReDream Brands Launches as the Leading Direct-to-Consumer Platform for Sleep Apnea and Sleep Health

New platform brings four of the industry's most recognized direct-to-consumer brands together to serve the cash-pay obstructive sleep apnea (OSA) market across North America NEW YORK, Aug. 17, 2026 /PRNewswire/ -- Cathay Capital  today announced the launch of ReDream Brands , a new consumer sleep health platform dedicated to helping millions of people achieve better sleep and healthier lives. The platform brings together four of the industry's most recognized direct-to-consumer brands: cpap.com, The CPAP Shop, Lofta and sleeping.com, creating a leading platform for cash-pay OSA customers across North America.

Aug 17, 2026 05:00 AM • prnewswire.com
AdaptHealth Corp. to Participate in Upcoming Investor Conferences

AdaptHealth Corp. to Participate in Upcoming Investor Conferences

CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) (“AdaptHealth” or the “Company”), a national leader in providing patient-centered, healthcare-at-home solutions including home medical equipment, medical supplies, and related services, announced today that they will participate in the following upcoming investor conferences: The Canaccord Genuity 46th Annual Growth Conference, being held in Boston, on Tuesday, August 11, 2026, including a fireside chat from 9:00 – 9:25 a.m. E.

Aug 07, 2026 12:05 PM • businesswire.com
AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)

AHCO Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into AdaptHealth Corp. (AHCO)

NEW YORK--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) shares fell as much as 26% after the Company reported second quarter revenue of $740.3 million, well below approximately $847 million expected, a GAAP loss driven in part by a $144.2 million goodwill impairment charge, and a substantial reduction to full-year guidance. If you suffered a loss on your AdaptHealth investment, you are encouraged to click here to submit your information. You may also contact Joseph E. Levi, Esq. via email a.

Aug 07, 2026 06:07 AM • businesswire.com (Hide legal announcements)
Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm

LOS ANGELES--(BUSINESS WIRE)--Glancy Prongay Wolke & Rotter LLP, a leading national shareholder rights law firm, today announced that it has commenced an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) investors concerning the Company's possible violations of the federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ADAPTHEALTH CORP. (AHCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. What Happened? O.

Aug 06, 2026 07:00 AM • businesswire.com (Hide legal announcements)
AdaptHealth Corp. (AHCO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

AdaptHealth Corp. (AHCO) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation

BENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces an investigation on behalf of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ADAPTHEALTH CORP. (AHCO), CONTACT THE LAW OFFICES OF HOWARD G. SMITH ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS. Contact the Law Offices of Howard G. Smith to discuss your legal rights by e.

Aug 06, 2026 05:00 AM • businesswire.com (Hide legal announcements)
AdaptHealth Q2 Earnings Call Highlights

AdaptHealth Q2 Earnings Call Highlights

AdaptHealth (NASDAQ: AHCO) reported second-quarter revenue growth in its continuing operations but lowered its full-year profitability outlook, citing higher-than-expected costs in its West Coast capitated contract, a supplier price increase and portfolio actions. Chief Executive Officer Suzanne Foster said the company delivered 15.9% organic revenue growth during the quarter, supported by record volume gains. Continuing-operations net

Aug 05, 2026 09:03 PM • defenseworld.net
Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

Securities Fraud Investigation Into AdaptHealth Corp. (AHCO) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz

LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) on behalf of investors concerning the Company's possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON ADAPTHEALTH CORP (AHCO), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is the Investigation About? On August 4, 2026, the Company reported second quarter results, in.

Aug 05, 2026 11:19 AM • businesswire.com (Hide legal announcements)
AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Holzer and Holzer, LLC is investigating whether AdaptHealth Corp. ("AdaptHealth" or the "Company") (NASDAQ: AHCO) complied with federal securities laws. On August 4, 2026, AdaptHealth revised its financial guidance and announced second quarter 2026 results, revealing that "[c]ash flow from operations was $239.

Aug 04, 2026 09:09 AM • globenewswire.com (Hide legal announcements)
AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

AHCO INVESTOR ALERT: Investigation of AdaptHealth Corp. Announced by Holzer & Holzer, LLC

ATLANTA, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Holzer & Holzer, LLC is investigating whether AdaptHealth Corp. (“AdaptHealth” or the “Company”) (NASDAQ: AHCO) complied with federal securities laws. On August 4, 2026, AdaptHealth revised its financial guidance and announced second quarter 2026 results, revealing that “[c]ash flow from operations was $239.0 million year-to-date 2026, a decrease from $257.5 million during the comparable period in 2025, and free cash flow was negative $48.4 million year-to-date 2026, compared to $73.3 million during the comparable period in 2025.” AdaptHealth attributed the results in part to its “West Coast capitated partnership reach[ing] full scale in the quarter, and the complexity of the transition” impacting margins. On this news, the price of the Company's stock dropped.

Aug 04, 2026 09:09 AM • globenewswire.com (Hide legal announcements)

Price Targets